Cogentix Medical (Cogentix Medical) 5-Year Dividend Growth Rate : 0.00% (As of Dec. 2017)

View and export this data going back to 1992. Start your Free Trial

What is Cogentix Medical 5-Year Dividend Growth Rate?

Cogentix Medical's Dividends per Share for the three months ended in Dec. 2017 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Cogentix Medical's Dividend Payout Ratio for the three months ended in Dec. 2017 was 0.00. As of today, Cogentix Medical's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Cogentix Medical's 5-Year Dividend Growth Rate

For the Medical Devices subindustry, Cogentix Medical's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cogentix Medical's 5-Year Dividend Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cogentix Medical's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Cogentix Medical's 5-Year Dividend Growth Rate falls into.

Cogentix Medical 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Cogentix Medical (NAS:CGNT) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Cogentix Medical's Dividend Payout Ratio for the quarter that ended in Dec. 2017 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2017 )	/	EPS without NRI (Q: Dec. 2017 )
	=	0	/	0.01
	=	0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cogentix Medical 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of Cogentix Medical's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Cogentix Medical (Cogentix Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cogentix Medical Inc (NAS:CGNT) » Definitions » 5-Year Dividend Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

5420 Feltl Road, Minnetonka, MN, USA, 55343

Website

http://www.cogentixmedical.com

Cogentix Medical Inc is a medical device company. The company designs, develops, manufactures and markets a robust line of high-performance fiberoptic and video endoscopy products under the PrimeSight brand that is used across multiple surgical specialties in diagnostic and treatment procedures. Cogentix offers the Urgent PC Neuromodulation System, a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). It also develops Macroplastique an injectable, urethral bulking agent for the treatment of adult female stress urinary incontinence primarily resulting from intrinsic sphincter deficiency.

Executives

Nachum Shamir	director	12212 TECHNOLOGY BLVD, AUSTIN TX 78727
Brett Reynolds	officer: SVP, CFO, Treasurer	5000 W 36TH STREET, MINNEAPOLIS MN 55416
Kenneth A Samet	director	800 KING FARM BOULEVARD, 4TH FLOOR, ROCKVILLE MD 20850
Uri Geiger	director	221 LATHROP WAY, SUITE I, SACRAMENTO CA 95815
Accelmed Growth Partners, L.p.	10 percent owner	6 HACHOSHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Accelmed Growth Partners Management Ltd.	10 percent owner	6 HACHOCHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Accelmed Growth Partners (gp), L.p.	10 percent owner	6 HACHOCHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Accelmed Growth Partners (agp) Ltd	10 percent owner	6 HACHOCHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Cheryl Pegus	director	40 RAMLAND ROAD, ORANGEBURG CA 10962
Kenneth H Paulus	director	5420 FELTL ROAD, MINNETONKA MN 55343
Sven Wehrwein	director
Kevin H Roche	director
David W Anderson	director	519 LYNMERE ROAD, BRYN MAWR PA 19010